Pharma Journalist 8801 posts 0 comments

Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) in…
Read More...

Neuroptika announced that the first patient was enrolled in a Phase 2 clinical trial of NRO-1 for the treatment of dry eye disease. NRO-1 is a novel therapeutic with the potential to…
Read More...

Twist Bioscience Corporation announced a collaboration with Schrödinger, Inc. to bring the two companies’ technology platforms together to discover new antibody therapeutics against…
Read More...

Azymus Therapeutics, an emerging pharmaceutical company, is advancing 10-years of nano-therapeutic research supported by its AZ Platform. The company's researchers are studying…
Read More...

Bayer and WuXi Biologics have entered into an agreement that WuXi Biologics Germany GmbH will take over operations of one of Bayer’s final drug product manufacturing plants in…
Read More...

Sun Pharmaceutical Industries Ltd. announced that one of its wholly owned subsidiaries has entered into exclusive licensing and supply agreements with Rockwell Medical Inc. (Rockwell),…
Read More...

NuMedii, Inc. announced a new partnership with a drug delivery company to develop new therapeutics for ulcerative colitis. The collaboration will bring together NuMedii's NM-001 asset…
Read More...

Artisan Bio, Inc., a stealth cell therapy engineering company, announced it has entered into a global research and collaboration agreement with Takeda Pharmaceutical Company Limited for…
Read More...

AstraZeneca and MSD Inc., Kenilworth, N.J., US announced that a supplemental New Drug Application for Lynparza (olaparib) in combination with bevacizumab has been accepted and granted…
Read More...

Galapagos NV and Fibrocor Therapeutics Inc. announced an expanded collaboration focused on novel targets in fibrosis, with Galapagos taking an equity stake in Fibrocor. Fibrocor is a…
Read More...